WHO ICTRP trial
Management of Aamavata through Ayurveda
CTRI/2021/04/033222 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2021/04/033222 |
|---|---|
| Public title | Management of Aamavata through Ayurveda |
| Scientific title | CLINICAL STUDY OF SHTAYADI KWATHA IN THE MANAGEMENT OF AAMAVATA (RHEUMATOID ARTHRITIS) - RA |
| Primary sponsor | Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified |
| Interventions | Intervention1: Shtayadi Kwatha: Shtayadi Kwatha in the dose of 20 ml twice a day for 90 days Control Intervention1: NIL: NIL |
| Registration date | Apr 28, 2021 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: